These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28033293)

  • 1. Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results.
    Hu S; Tu J; Jia Z; Huang Y; Jiang G
    Medicine (Baltimore); 2016 Dec; 95(52):e5762. PubMed ID: 28033293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplemental conventional transarterial embolization/chemoembolization therapy via extrahepatic arteries for hepatocellular carcinoma.
    Huang Y; Jia Z; Tu J; Shen T; Tian F; Jiang G
    J Cancer Res Ther; 2017; 13(4):720-724. PubMed ID: 28901321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical value of transcatheter arterial chemoembolization therapy for hepatocellular carcinoma with blood supply from right adrenal artery].
    Liao GS; Liu X; Luo XP; He MJ; Yang W
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):835-841. PubMed ID: 30616318
    [No Abstract]   [Full Text] [Related]  

  • 4. [Extrahepatic collateral arteries are involved in the blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization].
    Li Q; Yang RJ; Zhu X; Zhu LZ; Wang MQ; Duan F
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):613-7. PubMed ID: 24314221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplemental transcatheter arterial chemoembolization for hepatocellular carcinoma fed by collateral omental artery.
    Jia Z; Tian F; Li S; Wang K; Zhao J; Wang Y; Jiang L; Jiang G; Li M
    Hepatogastroenterology; 2014 Oct; 61(135):2042-6. PubMed ID: 25713908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
    Shin BS; Park MH; Jeon GS
    Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization.
    Kimura S; Okazaki M; Higashihara H; Haruno M; Nozaki Y; Urakawa H; Kora S; Shinagawa Y; Nonokuma M
    Hepatogastroenterology; 2009; 56(89):191-8. PubMed ID: 19453056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
    Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
    Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
    J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery.
    Shen T; Jia Z; Huang Y; Li S; Jiang G; Cheng L
    Medicine (Baltimore); 2017 Nov; 96(45):e8634. PubMed ID: 29137099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma.
    He M; Li Q; Shen J; Tan G; Li Q; Lai J; Wei W; Zhang Y; Zou R; Chen M; Guo R; Shi M
    Cancer Med; 2019 Aug; 8(9):4200-4213. PubMed ID: 31207163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization.
    Lanza E; Muglia R; Bolengo I; Poretti D; D'Antuono F; Ceriani R; Torzilli G; Pedicini V
    PLoS One; 2020; 15(1):e0227711. PubMed ID: 31935255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
    Tang C; Shen J; Feng W; Bao Y; Dong X; Dai Y; Zheng Y; Zhang J
    Medicine (Baltimore); 2016 May; 95(20):e3754. PubMed ID: 27196501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
    Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
    J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents.
    Chen S; Yu W; Zhang K; Liu W; Chen Q
    Medicine (Baltimore); 2018 May; 97(21):e10832. PubMed ID: 29794774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.